Effect of vitamin E addition to poly(D,L)-lactic acid on surface properties and osteoblast behaviour

Vitamin E (Vit.E, alpha-tocoferol) is a natural agent with anti-oxidative and anti-inflammatory properties and it has been suggested that it could act as a stimulating factor for osteoblast proliferation and maturation. We produced poly(D,L)-lactic acid films enriched with Vit.E (1, 5 and 10% w/w) and investigated their surface properties using the FTIR analysis, sessile measure of wettability and serum protein adsorption, and evaluated attachment and spreading of MC-3T3 E1 murine osteoblast cells. FTIR analysis showed the presence of Vit.E on the polymer surface and Vit.E increased the polymer wettability in a concentration-dependent manner. The serum total protein adsorption increased significantly onto the 10% Vit.E P(D,L)-LA and the main protein adsorbed was albumin. The presence of albumin, considered as an anti-adhesive protein, on the surface of Vit.E enriched P(D,L)-LA films (especially 5 and 10% Vit.E) could explain, at least in part, the behaviour of MC-3T3 osteoblast cells seeded onto the polymers. Cell adhesion and spreading were strongly decreased by Vit.E (5 and 10%) in spite of the increased wettability. This reaction could be cell type-specific, independent by the surface wettability and linked to cell-specific characteristics (membrane phospholipid composition, integrins expression). Moreover a direct effect of Vit.E on cell adhesion and spreading cannot be completely excluded.     

Erosion of biodegradable block copolymers made of poly( -lactic acid) and poly(ethylene glycol)

Biodegradable block copolymers made of poly(ethylene glycol) monomethylether (Me.PEG) and poly( -lactic acid) (PLA) were investigated for their erosion properties. Wide angle X-ray diffraction (WAXD) and differential scanning calorimetry (DSC) investigations prior to erosion revealed that despite the low content of crystallizable Me.PEG of 10%, Me.PEG5-PLA45 is a partially crystalline polymer. The erosion of the polymer was investigated using cylindrical polymer matrix discs with a diameter of 8mm and a height of 1.5mm. WAXD and DSC spectra obtained from eroded polymer matrix discs suggest that both polymer blocks separate completely during erosion. The crystallinity of Me.PEG5-PLA45 was found to increase during erosion, which is probably due to the improved mobility of Me.PEG inside the polymer with a progressive degree of degradation. The erosion kinetics were found to be similar to that of PLA or poly(lactic-co-glycolic acid). During erosion the polymer matrix weight of dried samples remains constant for 11 weeks after which erosion sets in rapidly. From this observation one can conclude that the impact of the relatively small Me.PEG chains on Me.PEGS-PLA45 erosion is not pronounced. This is beneficial for all those applications that require the stability of the polymer matrix and in which the Me.PEG chain is intended to bring about other effects such as the modification of the surface properties of PLA polymers.     

Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel

Microspheres of a new kind of copolymer, poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA), are proposed in the present work for clinical administration of an antineoplastic drug paclitaxel with hypothesis that incorporation of a hydrophilic PEG segment within the hydrophobic PLA might facilitate the paclitaxel release. Paclitaxel-loaded PLA-PEG-PLA microspheres of various compositions were prepared by the solvent extraction/evaporation method. Characterization of the microspheres was then followed to examine the particle size and size distribution, the drug encapsulation efficiency, the colloidal stability, the surface chemistry, the surface and internal morphology, the drug physical state and its in vitro release behavior. The effects of polymer types, solvents and drug loading were investigated. It was found that in the microspheres the PEG segment was homogeneously distributed and caused porosity. Significantly faster release from PLA-PEG-PLA microspheres resulted in comparison with the PLGA counterpart. Incorporation of water-soluble solvent acetone in the organic solvent phase further increased the porosity of the PLA-PEG-PLA microspheres and facilitated the drug release. A total of 49.6% sustained release of paclitaxel within 1 month was achieved. Potentially, the presence of PEG on the surface of PLA-PEG-PLA microspheres could improve their biocompatibility. PLA-PEG-PLA microspheres could thus be promising for the clinical administration of highly hydrophobic antineoplastic drugs such as paclitaxel.     

Biodegradation of Thermoplastic Starch and its Blends with Poly(lactic acid) and Polyethylene: Influence of Morphology

The room temperature mineralization of thermoplastic starch (TPS) with a high glycerol content and its blends with low‐density polyethylene (LDPE) and polylactic acid (PLA) are examined under controlled degradation conditions. These results are correlated with the morphologies and continuity behavior of the various blend systems. It is found that thermoplastic starch degrades more rapidly than native starch. Lowering the glycerol content in the TPS has virtually no effect on its biodegradation behavior. The only contribution to biodegradation of the TPS blend is from the TPS component. Blending TPS with LDPE and PLA in a co‐continuous morphology at a 50/50 composition provides a significant increase in TPS surface area, which increases the biodegradation rate for the blends as compared to pure TPS. The results indicate a close relationship between morphology, phase continuity, and biodegradation behavior.

     

Preparation of poly(lactic acid) composites containing calcium carbonate (vaterite)

A new type of ceramic-polymer biomaterial having excellent apatite-forming ability in simulated body fluid was prepared by hot-pressing a mixture of poly(-L-lactic acid) (PLA) and calcium carbonate (vaterite). After PLA dissolved in methylene chloride was mixed with calcium carbonate consisting of vaterite, the mixture was dried completely and subsequently hot-pressed uniaxially under a pressure of 40 MPa at 180 degrees C. When 30 wt% vaterite was introduced, the modulus of elasticity was effectively improved by 3.5-6 GPa, which was about twice higher than the modulus of PLA. The composite showed no brittle fracture behavior and a comparably high bending strength of approximately 50 MPa. The composite containing 30 wt% vaterite formed a 5-15-microm-thick bonelike apatite layer on its surface after soaking in SBF at 37 degrees C even for 1-3d.     

美斯地浓聚乳酸载药纳米粒的制备及体外释放

背景：美斯地浓临床常用于治疗重症肌无力,但其水溶性较强,半衰期短,生物利用度低,给药频率高,患者依从性差,因此提高其缓释作用对临床应用有重要意义。 目的：制备美斯地浓聚乳酸纳米粒,并考察其体外释放性能。 方法：以聚乳酸为载药材料,采用复乳液中干燥法制备美斯地浓聚乳酸纳米粒,运用单因素实验设计优化处方,动态透析法进行体外药物释放实验。 结果与结论：确定以二氯甲烷作为油相制备纳米粒,内水相与油相的比例1∶10,聚乳酸浓度6%,外水相聚乙烯醇浓度3%,美斯地浓投药量40 mg为最佳制备工艺,此条件制备的药物纳米粒包封率和载药率分别为(67.59±1.46)%和(4.31±0.17)%。美斯地浓聚乳酸纳米粒的平均粒径为937 nm,圆球形,表面光滑,未观察到粘连现象。与美斯地浓游离药物相比,美斯地浓聚乳酸纳米粒存在突释现象,之后呈现缓慢释放特性,72 h释放量为57.03%,提示成功制备美斯地浓聚乳酸纳米粒,具有缓释效应。     

Stereocomplexes based on poly(lactic acid) and insulin: formulation and release studies

Diastereoisomeric complexes of insulin with D-poly(lactic acid) (D-PLA) or stereocomplexes of D- and L-PLA entrapping insulin were discovered. The complexes were spontaneously formed when insulin and D-PLA were mixed together in acetonitrile solution. Complexes of insulin-D-PLA formed a microparticulate precipitate after a few hours in the solution. The porous 1-3 microm precipitate, which contained both insulin and D-PLA, was insoluble in solvents that dissolve isotactic PLA, and had an additional transition temperature at 169 degrees C. When suspending these particles in buffer solution of pH 7.4, 37 degrees C, insulin was constantly released for a few weeks. L-PLA or D,L-PLA did not form a precipitate with insulin, which indicates stereospecificity to the complex formation. Microparticulates were also obtained when L-PLA was added to the D-PLA-insulin solution. In this case two types of complexes, D-PLA-insulin and D-PLA-L-PLA complexes, were formed. These macromolecular stereocomplexes may form the onset of the development of a new generation of controlled release systems for peptides and proteins, by molecular complexation with enantiomeric polymers.     

Biodegradable honeycomb-patterned film composed of poly(lactic acid) and dioleoylphosphatidylethanolamine

Honeycomb-patterned films have been reported to be useful for scaffolds of cell culture in tissue engineering. In the present study, we investigated a new compound, dioleoylphosphatidylethanolamine (DOPE), a naturally derived phospholipid having unsaturated fatty acid moieties, as a surfactant for fabricating honeycomb-patterned poly(d,l-lactide) (PLA) film. Only DOPE among commercially available phospholipids was useful as a surfactant, and it showed good solubility in PLA/chloroform solution and an excellent property for fabricating honeycomb-patterned film (the concentration of DOPE was from 0.2% to 20% by weight based on the weight of PLA). The pore size of the honeycomb was uniform, and all pores were interconnected with each other. The contact angle of water on the honeycomb-patterned film was affected by the amount of DOPE. Time-of-flight secondary ion mass spectrometer (TOF-SIMS) data suggested that DOPE was concentrated on the surface of the honeycomb-patterned film. To investigate cell proliferation and adhesion on the honeycomb-patterned film, NIH3T3 fibroblast cells were cultured on the film. The NIH3T3 cells adhered well on the honeycomb-patterned PLA film with DOPE (PLA-DOPE) and showed good cell proliferation compared to that on honeycomb-patterned PLA film fabricated with a copolymer (CAP) of dodecylacrylamide and omega-carboxyhexylacrylamide (PLA-CAP). These results suggest that the honeycomb-patterned PLA-DOPE can be applicable as a scaffold for cells with better profiles in comparison with PLA-CAP.     

Characterization of co-polymers of lactic and glycolic acid for supercritical fluid processing

Polymers of lactic and glycolic acid are often used for the production of injectible microparticles with controlled drug release. In the variety of processes used for the microparticle formulation, the Aerosol Solvent Extraction System (ASES) is rather special. Microparticle formation and drying take place in one step by precipitating a methylene chloride solution of the polymer in supercritical CO2. This process sets special requirements to the polymers in crystallinity, solubility, and thermal behavior that are best fulfilled by blocked copolymers. This study investigates a number of lactide-co-glycolide polymers with blocked distribution of the co-monomers by NMR spectroscopy and powder diffraction. The molar ratios are determined by 1H-NMR spectroscopy to verify the manufacturer's declarations of the purchased specimens. Additionally, the block length is determined by application of 13C-NMR. Therefore, a method reported in the literature was modified and evaluated in order to calculate the length of lactide and glycolide sequences in the polymer. Furthermore, this study looks at the impact of synthesis conditions on block length and crystallinity, and the impact of the blocking on both, crystallinity and solubility of the polymers.     

Oppositely Synchronized Lamellar Bending in Poly(l‐lactic acid) Versus Poly(d‐lactic acid) Blended with Poly(1,4‐butylene adipate)

Lamellar bending habits, as influenced by molecular‐chain chirality, in packing into dendritic spherulites with specific optical patterns are discussed using two model polymers of opposite chirality that are blended with a common polymer as examples: i) poly(l ‐lactic acid)/poly(butylene adipate) (PLLA/PBA) and ii) poly(d ‐lactic acid)/PBA (PDLA/PBA) blends. The bending habits in the spherulites of PLLA or PDLA blended with PBA are dictated by the chirality, specifically the counterclockwise and clockwise directions for the PLLA/PBA (50:50) and PDLA/PBA (50:50) blends, respectively. Straight lamellae in spiral lozenge crystals are packed with crystal aggregates of PLLA on top of the flat‐on lamellae plates acting as a basal plane during crystallization at T_c; spiral lozenge‐crystal frameworks are surrounded by needle‐like crystals resembling PBA crystals.

     

Grafting reaction of poly(D,L)lactic acid with maleic anhydride and hexanediamine to introduce more reactive groups in its bulk

Bioactivity of biomaterials was a new requirement, especially in tissue engineering and drug delivery. As a traditional used biomaterial, polylactide (PLA) had no bioactivity, of course, and it still had few reactive groups to introduce some bioactive molecules in its bulk. Here, we want to introduce carboxyl groups and amino groups in the side chain of PLA to get more reactive groups for incorporating bioactive molecular later and to maintain the structure of main chain to keep its biodegradability, and to settle the acidity of PLA during hydrolysis at the same time. It was performed as follows: first, maleic anhydride was covalently grafted onto the side chain of PLA by a free radical reaction at 100 degrees C for 20 h with BPO as the initiator. Then, by amidation with a maleic anhydride group on PLA at room temperature, hexanediamine was incorporated. The resulting polymers have been characterized via GPC, (13)C NMR, DSC, and TGA. The graft ratio was tested by titration. The pH changes during hydrolysis in 0.1 M PBS with pH 7.4 of PLA, MPLA, and HPLA were investigated. All the results showed that this research has grafted maleic anhydride and then hexanediamine in the bulk of PLA. The molecular weight degradation during reaction was less than 20%. The graft ratios of were 2.68, 2.36, and 1.86%, respectively in 5, 10, and 20% raw MA in MPLA; and the anhydride groups grafted in MPLA can completely react with hexanediamine at room temperature. The pH value of HPLA remained neutral within 12 weeks' hydrolysis compared with the resulted acidity of PLA and MPLA.     

D,L-聚乳酸基形状记忆聚合物的生物安全性和细胞相容性

背景：课题组前期实验研制了输卵管避孕器材料D, L-聚乳酸基形状记忆聚合物,依据国内《生物材料和医疗器材生物学评价技术要求》规定,植入体内的组织工程材料必须进行生物安全评价和细胞相容性实验。 目的：观察D, L-聚乳酸基形状记忆聚合物的生物安全性。 方法：①内毒素实验：在鲎试剂中分别加入聚合物浸提液、内毒素工作标准品溶液和细菌内毒素检查用水。②致敏实验：在昆明小鼠肩胛骨内侧分别注射聚合物浸提液+弗氏完全佐剂+生理盐水、弗氏完全佐剂+生理盐水,通过皮内诱导、局部诱导和激发阶段,观察动物激发部位皮肤红斑和水肿反应程度。③急性毒性实验：分别在昆明小鼠腹腔注射100%,50%,25%聚合物浸提液及生理盐水。④细胞增殖MTT实验：直接法为将人脐静脉内皮细胞分别接种于聚合物膜、聚乳酸与玻璃片上;间接法为将人脐静脉内皮细胞分别接种于聚合物浸提液、丙烯酰胺溶液及1640培养液。 结果与结论：D, L-聚乳酸基形状记忆聚合物材料无细菌污染状况,符合生物安全标准,无致敏性及毒性,并且具有较好的细胞相容性。     

Transparent micro- and nanopatterned poly(lactic acid) for biomedical applications

The formation of structures in poly(lactic acid) has been investigated with respect to producing areas of regular, superficial features with dimensions comparable to those of cells or biological macromolecules. Nanoembossing, a novel method of pattern replication in polymers, has been used for the production of features ranging from tens of micrometers, covering areas up to 1 cm(2), down to hundreds of nanometers. Both micro- and nanostructures are faithfully replicated. Contact-angle measurements suggest that positive microstructuring of the polymer (where features protrude from the polymer surface) produces a more hydrophilic surface than negative microstructuring. The ability to structure the surface of the poly(lactic acid), allied to the polymer's postprocessing transparency and proven biocompatibility, means that thin films produced in this way will be useful for bioengineers studying the interaction of micro- and nanodimensioned features with biological specimen, with regard to tissue engineering, for example.     

壳聚糖-明胶/聚乳酸-羟基乙酸联合载药水凝胶的体外抗结核作用

文题释义：基质细胞衍生因子1：是一种参与免疫细胞活化、分化和迁移及伤口愈合、角膜上皮再生和组织修复等过程的趋化因子,能促进干细胞的生长和发育,参与调节成骨分化,可通过细胞归巢提高干细胞向病灶区的趋化作用。而基质细胞衍生因子1的失活会损害成骨细胞的发育和分化。此外,其还与血管生成密切相关。 异烟肼：具有较高的杀菌活性,是治疗结核病的一线药物。世卫组织建议将异烟肼作为结核病的标准疗法,用于潜伏性结核病感染者的预防治疗,与利福平、吡嗪酰胺和乙胺丁醇一起用于治疗活动性肺结核。异烟肼的活化形式与脂肪酸生物合成Ⅱ型系统中的NADH依赖型烯醇酰基载体蛋白还原酶异烟肼a结合,阻断细菌细胞壁关键成分支原体酸的合成。 背景：抗结核化疗是目前治疗骨关节结核的主要手段,然而全身给药难以维持病灶区的有效浓度,治疗效果欠佳。 目的：制备一种原位、长期释放抗结核药物且兼备促成骨作用的壳聚糖-明胶/聚乳酸-羟基乙酸联合载药水凝胶。 方法：将亲水性的抗结核药物异烟肼和疏水性的基质细胞衍生因子通过复乳法负载到聚乳酸-羟基乙酸中,制备聚乳酸-羟基乙酸载药微球,共混至壳聚糖-明胶水凝胶支架中,制备壳聚糖-明胶/聚乳酸-羟基乙酸联合载药水凝胶。检测聚乳酸-羟基乙酸载药微球、壳聚糖-明胶/聚乳酸-羟基乙酸联合载药水凝胶的体外释药与抗结核杆菌的能力。将成骨前体细胞MC3T3-E1分别接种于载药微球与联合载药水凝胶表面,CCK-8法检测细胞活力,碱性磷酸酶活性检测细胞的成骨性能。 结果与结论：①载药微球中异烟肼1 h内的突释约为23.3%,2 d内的释放率约为42.6%,随后进入缓释期,25 d后进入平台期;基质细胞衍生因子1在1 h内的累积释放率约为19.8%,2 d内的释放率约为44.7%,随后进入缓释期,25 d后进入平台期;联合载药水凝胶中异烟肼和基质细胞衍生因子1最初1 h的释放分别为8.3%和8.5%,第2天的累计释放率分别为15.2%和17.6%,远低于聚乳酸-羟基乙酸微球;②体外4周后,联合载药水凝胶的抑菌直径大于载药微球,抑菌率高于载药微球(P < 0.05);③联合载药水凝胶与载药微球均具有良好的细胞相容性,细胞活力均约为100%;④培养5,10 d后,联合载药水凝胶表面的细胞碱性磷酸酶活性与载药微球比较差异无显著性意义(P > 0.05);⑤结果表明,原位壳聚糖-明胶/聚乳酸-羟基乙酸联合载药水凝胶有作为治疗骨关节结核及其他骨关节感染的潜力。 ORCID: 0000-0003-4166-2492(张贺龙) 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程     

聚乳酸的合成与降解机理

聚乳酸是近年来获得广泛应用的生物相容性良好的生物材料。本文综述了聚乳酸在合成与降解方面研究的最新进展,分别对聚合与降解机理进行了总结与评述。     

Preparation and characterization of zwitterionic phospholipid polymer-coated poly(lactic acid) nanoparticles

Poly(lactic acid) (PLA) nanoparticles (NPs) are the most promising polymer NPs for drug delivery and targeting. However, they are easily recognized as a foreign body and rapidly cleared from the body by the mononuclear phagocyte system. Cell membrane mimetic random copolymers, bearing both zwitterionic phosphorylcholine groups and hydrophobic butyl side chains (PMB) and additional cross-linkable trimethoxysilylpropyl side chains (PMBT), were synthesized and coated on PLA NPs. Effects of the zwitterionic copolymer coatings on the NP size distribution, dispersion stability, and drug release behavior were investigated. Furthermore, the effect of the coatings on phagocytosis was also investigated. Compared with conventional polyvinyl alcohol coating, the cell membrane mimetic copolymer coatings decreased the size and increased the stability of the PLA NPs aqueous dispersions. More importantly, doxorubicin (DOX) release was well controlled and NPs phagocytosis by mouse peritoneal macrophage was decreased to one-third when the nanoparticles were coated with PMBT. This simple and effective zwitterionic polymer coating strategy may serve as a new route to design and optimize long-circulating intravenously injectable nanoparticle drug carriers.     

Release of propranolol and diclofenac from low Mw DL-poly(lactic acid)

The controlled release of two drugs, i.e. the sodium salt of diclofenac and propranolol was studied, by using low molecular weight D,L-Poly(lactic acid) as a matrix. Tablets of the above polymer containing those drugs were immersed into buffers with various pH values and delivery was recorded as a function of time, via UV-spectroscopy. The results showed that the polymer is appropriate for such biomedical applications, as generally, it ensures complete drug delivery within 45-60 days, which is acceptable for most cases. On the other hand, the release rate depends on many parameters including the interactions among drug, matrix and the surrounding liquid, which adds complexity to the process and requires careful investigation for proper design of a controlled release system.     

Conducting Poly(anilineboronic acid) Nanostructures: Controlled Synthesis and Characterization

Self‐doped poly(anilineboronic acid) (PABA) nanostructures have been prepared by chemical polymerization in an aqueous acid solution and aliphatic alcohols. In aliphatic alcohols, PABA is soluble under the polymerization conditions. According to ¹¹B NMR studies, the formation of anionic tetrahedral boronate ester in aliphatic alcohols in the presence of fluoride forms the basis of self‐doped, soluble PABA. Transmission electron microscope images show the formation of nanostructures with different shapes and forms in different solvents after precipitation of the polymer as a result of ion exchange in the presence of 0.5 M HCl. The spectroscopic and cyclic voltammetric results confirm the formation of conducting PABA nanostructures in high yield. The conductivity of PABA thin films made from the nanostructures prepared in aqueous acid, methanol, ethanol and 1‐propanol is approximately 15 and 3.0, 2.1 and 1.9 S · cm^?1, respectively. The conducting PABA nanostructures are processable since they are easily re‐dispersed in the various solvents up to approximately 5 mg · mL^?1. UV‐vis kinetic measurements, XPS and ¹¹B NMR results suggest that the formation of various nanostructures is influenced by the polymerization rate, the degree of self‐doping versus external doping, and the polarity of the solvents used. The PABA nanostructured films produced from these structures exhibit enhanced redox stability in a wider potential window in non‐aqueous media compared to polyaniline due to formation of six‐member heterocyclic complexes containing a boron‐imine dative bond resulting in a self‐doped self‐cross‐linked polymer. The degree of crosslinking depends on the nature of nanostructures. In non‐aqueous media, the self‐doped, self‐cross‐linked PABA nanostructured films are much less susceptible to cathodic and anodic degradation at extreme potentials, overcoming a major limitation of more common conducting polymers.

     

聚乳酸降解材料的绿色化学合成

背景：聚乳酸具有良好的生物相容性和生物降解性,广泛应用于药物缓释、手术缝合线、组织工程支架及骨修复材料等生物医用领域。但其常规合成方法需使用溶剂,生产效率较低且成本较高。 目的：对非溶剂的绿色化学方法-乳酸熔融缩聚/二异氰酸酯熔融扩链,合成聚乳酸降解材料的研究进展进行综述。 方法：应用计算机检索SCI-Expanded数据库(1995-01/2010-06),以“Poly(lactic acid),diisocyanate”为检索词;应用计算机检索中国期刊网络出版总库(1999-01/2010-06),以“聚乳酸,异氰酸酯”为检索词。共收集130篇关于乳酸熔融缩聚/二异氰酸酯熔融扩链的文献,中文39篇,英文91篇。排除发表内容重复、实验结果较差的文献,共32篇文献符合标准被纳入。 结果与结论：采用非溶剂的绿色化学方法-乳酸熔融缩聚/二异氰酸酯熔融扩链,通过改变异氰酸酯和预聚物的种类和比例,就可以制备具有不同相对分子质量和性能的可降解聚乳酸基聚氨酯材料,有望在生物医用领域和日常生活中取得实际的应用。     

Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres

The immune response induced in mice by beta-galactosidase (beta-gal) adsorbed or encapsulated on poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) microspheres was investigated. The encapsulated protein elicited higher antibody response than the protein adsorbed on the microspheres in the case of the PLA microspheres. However, the encapsulated protein elicited weaker antibody response than the adsorbed protein in the case of the PLGA (50:50) microspheres, probably because, in this case, the encapsulation process adversely affected protein immunogenicity. In the case of adsorbed beta-gal, higher antibody response was obtained with the PLA microspheres than with the PLGA (50:50) microspheres. This may be related to the lower rate of beta-gal desorption from the PLA microspheres. Based on the immunoglobulin G1/immunoglobulin G2a ratios and the stimulation indices for interferon-gamma and interleukin-4, beta-gal encapsulated or adsorbed on PLA microspheres induced a Th(1)-biased immune response whereas beta-gal encapsulated or adsorbed on PLGA (50:50) microspheres induced a Th(2)-biased immune response. The results obtained indicate that more potent immune responses are obtained when the protein is encapsulated than adsorbed on the microspheres, providing that the encapsulation process does not adversely affect protein immunogenicity. Also, the type of polymer used to prepare the microspheres, but not the method of protein association with the microspheres, may affect the type of immune response.